DE69919963D1 - Magnesiumoxid enthaltendes Abführmittel - Google Patents

Magnesiumoxid enthaltendes Abführmittel

Info

Publication number
DE69919963D1
DE69919963D1 DE69919963T DE69919963T DE69919963D1 DE 69919963 D1 DE69919963 D1 DE 69919963D1 DE 69919963 T DE69919963 T DE 69919963T DE 69919963 T DE69919963 T DE 69919963T DE 69919963 D1 DE69919963 D1 DE 69919963D1
Authority
DE
Germany
Prior art keywords
magnesium oxide
evacuant
tablets
preparations
liquids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69919963T
Other languages
English (en)
Other versions
DE69919963T2 (de
Inventor
Ranko Inoue
Takeshi Inoue
Seiichi Yamagiwa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujix Corp
Original Assignee
Fujix Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujix Corp filed Critical Fujix Corp
Application granted granted Critical
Publication of DE69919963D1 publication Critical patent/DE69919963D1/de
Publication of DE69919963T2 publication Critical patent/DE69919963T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F11/00—Compounds of calcium, strontium, or barium
    • C01F11/02—Oxides or hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Geology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
DE69919963T 1998-11-26 1999-11-26 Magnesiumoxid enthaltendes Abführmittel Expired - Lifetime DE69919963T2 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP33483498 1998-11-26
JP33483498 1998-11-26
JP15826599 1999-06-04
JP15826599 1999-06-04
JP24236999 1999-08-30
JP11242369A JP2001048792A (ja) 1998-11-26 1999-08-30 瀉下剤

Publications (2)

Publication Number Publication Date
DE69919963D1 true DE69919963D1 (de) 2004-10-14
DE69919963T2 DE69919963T2 (de) 2005-09-22

Family

ID=27321316

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69919963T Expired - Lifetime DE69919963T2 (de) 1998-11-26 1999-11-26 Magnesiumoxid enthaltendes Abführmittel

Country Status (10)

Country Link
US (1) US6436447B1 (de)
EP (1) EP1004311B1 (de)
JP (1) JP2001048792A (de)
KR (1) KR100644149B1 (de)
CN (1) CN1263464C (de)
AT (1) ATE275407T1 (de)
AU (1) AU777206B2 (de)
CA (1) CA2291391C (de)
DE (1) DE69919963T2 (de)
TW (1) TW550078B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE380546T1 (de) * 2001-08-27 2007-12-15 Kyowa Chem Ind Co Ltd Antazide und laxative magnesiumoxid-tablette
WO2009057796A1 (ja) 2007-10-29 2009-05-07 Kyowa Chemical Industry Co., Ltd. 緩下剤
JP4714929B2 (ja) * 2008-02-29 2011-07-06 富田製薬株式会社 酸に不安定な薬剤用安定化剤
CA2758714C (en) 2009-04-22 2016-08-02 Kyowa Chemical Industry Co., Ltd. Tablet and pestle therefor
CN106029103B (zh) 2014-02-25 2021-12-31 神岛化学工业株式会社 医药用或食品添加用的氧化镁颗粒
JP2017190298A (ja) * 2016-04-13 2017-10-19 博 小田 体内で水素を産生する組成物、及びサプリメント
KR102592290B1 (ko) 2023-03-27 2023-10-20 주식회사 넘버제로 피처리물 분쇄장치
KR102592294B1 (ko) 2023-03-27 2023-10-20 주식회사 넘버제로 피처리물 파쇄장치

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58214338A (ja) * 1982-06-04 1983-12-13 Kyowa Chem Ind Co Ltd 複合吸着剤
JPH0940561A (ja) 1995-08-02 1997-02-10 Fujitsukusu Kk 瀉下剤

Also Published As

Publication number Publication date
CA2291391C (en) 2008-07-08
CA2291391A1 (en) 2000-05-26
KR100644149B1 (ko) 2006-11-13
EP1004311B1 (de) 2004-09-08
JP2001048792A (ja) 2001-02-20
DE69919963T2 (de) 2005-09-22
EP1004311A1 (de) 2000-05-31
AU6063599A (en) 2000-06-01
AU777206B2 (en) 2004-10-07
TW550078B (en) 2003-09-01
US6436447B1 (en) 2002-08-20
CN1263464C (zh) 2006-07-12
CN1255335A (zh) 2000-06-07
KR20000035693A (ko) 2000-06-26
ATE275407T1 (de) 2004-09-15

Similar Documents

Publication Publication Date Title
EP1334728A3 (de) Antitrombotische Mittel
EP1033624A4 (de) Chemisch verstärkte resist-zusammensetzung
GB2388786A (en) Dental floss with usage identification capability
EA199900075A1 (ru) Гранулят для получения быстрораспадающихся и быстрорастворяющихся композиций, содержащих большое количество лекарственного средства
WO2001076370A3 (en) Anthelmintic combinations
MXPA01012336A (es) Gel de silicon que contiene acido salicilico.
AU4579499A (en) Treatment of waste produced by farm animals raised under confined conditions
EP0890359A4 (de)
ATE359835T1 (de) Ein oxidationsmittel und ein hämolytisches mittel enthaltende artikel
AU764280C (en) Process for the preparation of pellets with a content of up to 90 wt. per cent of a pharmaceutical active ingredient
CA2265407A1 (en) Aqueous cleaning and disinfecting compositions which include quaternary ammonium compounds, block copolymer surfactants and further mitigating compounds which compositions featurereduced irritation
WO2002053101A3 (en) Method for treating fibrotic diseases or other indications
CA2391172A1 (en) Hydrocarbonaceous composition containing odor suppressant
AU2324100A (en) Positive resist composition of chemical amplification type
DE69919963D1 (de) Magnesiumoxid enthaltendes Abführmittel
CA2371925A1 (en) Antibacterial compositions
HK1029290A1 (en) Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions.
AU1279900A (en) Nightwear for children or incontinent persons
HUP0300357A3 (en) Control of parasites in animals, the novel active ingredients applied and compositions containing the same
EP1144712A4 (de) Gateoxid mit mehrfacher dicke, hergestellt durch sauerstoffimplantation
WO2002089832A3 (en) Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio.
AU1669897A (en) Silicone compositions containing UV degradable fungicides modified by incorporation of zinc oxide
ATE204764T1 (de) Absorbierendes und desinfizierendes mittel und dieses enthaltende vorrichtung
ZA200200340B (en) Storage of microorganisms, cells and tissue.
WO2002011740A3 (en) 'slow release' pharmaceutical compositions comprising lithium carbonate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition